articleTop 1% cited
Persistence and Adherence With Topical Glaucoma Therapy
American Journal of Ophthalmology · 2005 · Vol. 140(4) · pp. 598.e1–598.e11
Beth Nordstrom✉David S. Friedman(Johns Hopkins University)Essy Mozaffari(Pfizer (United States))Harry A. Quigley(Johns Hopkins University)Alexander M. Walker
Glaucoma and retinal disordersRetinal Diseases and TreatmentsMedicineGlaucomaDiscontinuationHazard ratioConfidence intervalRetrospective cohort studyInternal medicineMedical prescriptionGlaucoma medicationPediatrics
MeSH terms
Administration, TopicalAdrenergic alpha-AgonistsAdrenergic beta-AntagonistsAdultAgedAntihypertensive AgentsCarbonic Anhydrase InhibitorsDrug UtilizationFemaleGlaucoma, Open-AngleHumansInsurance, HealthIntraocular PressureMaleMiddle Aged
Citations
467
FWCI
13.66
field-weighted impact
References
28
Percentile
99%
vs. same field & year
Citations per year
References
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure:
American Journal of Ophthalmology · 2003 · 470 citations
The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration
American Journal of Ophthalmology · 2000 · 2,765 citations
The Ocular Hypertension Treatment Study
Archives of Ophthalmology · 2002 · 3,662 citations
Reduction of Intraocular Pressure and Glaucoma Progression
Archives of Ophthalmology · 2002 · 3,273 citations
Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes
American Journal of Epidemiology · 2003 · 2,088 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.